黑暗之心：曲妥珠单抗的弊端 - Suppr

Suppr

超能文献

Heart of darkness: the downside of trastuzumab.

作者信息

Hayes Daniel F, Picard Michael H

出版信息

J Clin Oncol. 2006 Sep 1;24(25):4056-8. doi: 10.1200/JCO.2006.07.5143. Epub 2006 Aug 14.

DOI:10.1200/JCO.2006.07.5143

PMID:16908930

Abstract

摘要

相似文献

Heart of darkness: the downside of trastuzumab.黑暗之心：曲妥珠单抗的弊端

J Clin Oncol. 2006 Sep 1;24(25):4056-8. doi: 10.1200/JCO.2006.07.5143. Epub 2006 Aug 14.

Trastuzumab trials steal show at ASCO meeting.曲妥珠单抗试验在ASCO会议上抢尽风头。

J Natl Cancer Inst. 2005 Jun 15;97(12):870-1. doi: 10.1093/jnci/97.12.870.

Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson Cancer Center experience.曲妥珠单抗在转移性乳腺癌中的长期心脏耐受性：MD安德森癌症中心的经验

J Clin Oncol. 2006 Sep 1;24(25):4107-15. doi: 10.1200/JCO.2005.04.9551. Epub 2006 Aug 14.

Trastuzumab faces trials, clinical and otherwise.曲妥珠单抗面临着各种试验，包括临床试验及其他方面的试验。

J Natl Cancer Inst. 2006 Mar 1;98(5):296-8. doi: 10.1093/jnci/djj110.

Bevacizumab and heart failure risk in patients with breast cancer: a thorn in the side?贝伐单抗与乳腺癌患者的心力衰竭风险：棘手问题？

J Clin Oncol. 2011 Feb 20;29(6):603-6. doi: 10.1200/JCO.2010.32.9060. Epub 2011 Jan 4.

Troponin I as a predictor for trastuzumab-related cardiotoxicity: current data do not provide mechanistic insights or allow for incorporation into clinical practice.

J Clin Oncol. 2011 Mar 1;29(7):e175-6. doi: 10.1200/JCO.2010.32.7353. Epub 2010 Dec 28.

Cardiac issues related to trastuzumab.

Breast. 2004 Jun;13(3):171-2. doi: 10.1016/j.breast.2004.02.008.

Trastuzumab cardiac side effects: only time will tell.曲妥珠单抗的心脏副作用：只有时间能给出答案。

J Clin Oncol. 2005 Nov 1;23(31):7775-6. doi: 10.1200/JCO.2005.04.1558.

Irreversible cardiotoxicity after adjuvant treatment with trastuzumab in a case of breast cancer.

Tumori. 2008 Sep-Oct;94(5):777-8. doi: 10.1177/030089160809400527.

Trastuzumab before breast surgery? Large trial says yes but does not quell debate.乳腺癌手术前使用曲妥珠单抗？大型试验给出肯定答案，但争议仍存。

J Natl Cancer Inst. 2009 Apr 1;101(7):448-9. doi: 10.1093/jnci/djp072. Epub 2009 Mar 24.

引用本文的文献

Anti-breast cancer activity of a novel genetically engineered fusion protein composed of HER2 affibody and proapoptotic peptide R8-KLA.由HER2亲和体与促凋亡肽R8-KLA组成的新型基因工程融合蛋白的抗乳腺癌活性

Med Oncol. 2025 Apr 9;42(5):155. doi: 10.1007/s12032-025-02707-3.

Design, synthesis, and cytotoxicity of ibuprofen-appended benzoxazole analogues against human breast adenocarcinoma.布洛芬附加苯并恶唑类似物对人乳腺腺癌的设计、合成及细胞毒性

RSC Med Chem. 2024 Jan 2;15(4):1283-1294. doi: 10.1039/d3md00479a. eCollection 2024 Apr 24.

Twenty-four-month Progression-free Survival in -amplified Advanced Gastric Cancer with Brain Metastases after Trastuzumab Deruxtecan Treatment: A Case Report and Literature Review.曲妥珠单抗德鲁昔单抗治疗后伴有脑转移的HER2扩增晚期胃癌的24个月无进展生存期：一例报告及文献综述

Curr Cancer Drug Targets. 2025;25(1):96-101. doi: 10.2174/0115680096283210240209062301.

Applying the New Guidelines of HER2 Testing in Breast Cancer.应用乳腺癌 HER2 检测新指南。

Curr Oncol Rep. 2020 Apr 29;22(5):51. doi: 10.1007/s11912-020-0901-4.

Shared Risk Factors in Cardiovascular Disease and Cancer.心血管疾病和癌症的共同风险因素。

Circulation. 2016 Mar 15;133(11):1104-14. doi: 10.1161/CIRCULATIONAHA.115.020406.

Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.乳腺癌幸存者关怀：长期医疗问题与生活方式建议的全面综述

Perm J. 2015 Spring;19(2):48-79. doi: 10.7812/TPP/14-241.

In situ quantitative measurement of HER2mRNA predicts benefit from trastuzumab-containing chemotherapy in a cohort of metastatic breast cancer patients.原位定量测量HER2mRNA可预测一组转移性乳腺癌患者接受含曲妥珠单抗化疗的获益情况。

PLoS One. 2014 Jun 26;9(6):e99131. doi: 10.1371/journal.pone.0099131. eCollection 2014.

Near-infrared quantum dots for HER2 localization and imaging of cancer cells.用于HER2定位和癌细胞成像的近红外量子点

Int J Nanomedicine. 2014 Mar 11;9:1323-37. doi: 10.2147/IJN.S51535. eCollection 2014.

First do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancer.首要原则是不造成伤害：基于人群的研究表明，非循证性的曲妥珠单抗处方可能会对老年乳腺癌女性造成伤害。

Breast Cancer Res Treat. 2014 Apr;144(2):417-25. doi: 10.1007/s10549-014-2874-1. Epub 2014 Feb 21.

HER-2/neu Marker Examination using Immunohistochemical Method in Patients Suffering from Gastric Adenocarcinoma.采用免疫组织化学方法对胃腺癌患者进行HER-2/neu标志物检测。

Int J Mol Cell Med. 2013 Fall;2(4):199-203.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验